Discover trends, market shifts, and competitive outlooks for the jynneos global market report 2025 industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the Jynneos Market’s Growth Trajectory From 2025 To 2034?

In recent times, the jynneos market has witnessed an XX (HCAGR) growth. Its size is predicted to increase from $XX million in 2024 to $XX million in 2025, with a compound annual growth rate (CAGR) of XX%. This expansion during the historic period is credited to factors such as the intensifying threat of newly emerging infectious diseases, augmented government funding for vaccinations, an increase in global travel, elevation in public health promotions, and enhancements in the vaccine distribution chain.

Over the coming years, the market size of Jynneos is predicted to experience an XX% (FCAGR) growth. By 2029, the expansion is anticipated to reach a total of $XX million, indicating a compound annual growth rate of XX%. Multiple factors can be attributed to this projected growth during the forecast period. These include a rising inclination towards infection prevention, tailored medication, enhanced emphasis on preparedness for infectious diseases within health systems, the injection of funding into vaccine production and supply infrastructure, and the upsurge of immunocompromised individuals. Major trends that are expected to prosper within this period are cutting-edge treatments, mRNA vaccine technology, the application of AI in vaccine development, revolutionary adjuvant systems, and unique formulas.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20118&type=smp

What are the Fundamental Drivers and Innovations Shaping the Jynneos Market?

The heightened incidence of monkeypox is projected to propel the jynneos market forward. Monkeypox is an infectious disease caused by the monkeypox virus, a member of the orthopoxvirus family. The surge in global travel along with expanding interactions between humans and wildlife often facilitate the swift transmission of infectious agents resulting in isolated outbreaks. Jynneos serves as an effective deterrent to monkeypox, mainly in high-risk individuals, and is safer than conventional smallpox vaccines for people with compromised immune systems. For example, the European Centre for Disease Prevention and Control stated in September 2024 that between January 2022 and July 2024, there were over 100,000 confirmed monkeypox cases, from MPXV clade I and II, leading to over 200 deaths, reported by more than 120 nations worldwide. Moreover, the European Centre for Disease Prevention and Control (ECDC), based in Sweden, indicated in May 2022 that from January to April 2022, there were 1,152 suspected monkeypox incidents, resulting in 55 fatalities and a case-fatality rate of 4.8%, spread over 54 health zones in 14 provinces. Consequently, the increasing reports of monkeypox are stimulating the growth of the Jynneos market.

How Is the Jynneos Market Segmented?

The jynneos market covered in this report is segmented –

1) By Indication: Prevention of Monkeypox, Prevention of Smallpox

2) By Formulation: Injectable Formulation, Lyophilized Powder for Reconstitution

3) By Patient Demographics: Adult Patients, Pediatric Patients, High-Risk Populations

4) By Distribution channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Specialty Clinics, Public Health Organizations, Home Healthcare Providers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20118&type=smp

Which Regions Are Driving the Next Phase of the Jynneos Market Growth?

North America was the largest region in the jynneos market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the jynneos market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/jynneos-global-market-report

How Is the Jynneos Market Defined and What Are Its Core Parameters?

Jynneos is a vaccine designed to protect both monkeypox and smallpox. It includes a modified, non-replicating vaccinia virus, which is similar to the virus used in traditional smallpox vaccines but does not replicate in the body. The immune response enables the body to recognize and fight off monkeypox and smallpox viruses if exposed in the future, providing long-lasting protection.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20118

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model